Shashikant B. Lele, MD
Clinical Chair & Professor of Oncology
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo,
NY
USA
14263
Biographical Sketch: Gynecologic Oncology Group Principal Investigator Gynecologic Oncology Group Board of Directors Society of Gyneocloigc Oncology Previous Presenter Present and attend 12th Gyn Oncology Congress – “ Early Detection in Ovarian Cancer” and “Robotic Assisted Surgery in Gynecologic Oncology” Antalya, Turkey, September 2010 Invited speaker, Federation of Ob & Gyn of India National Congress “Primary Surgical Cyto Reduction in Management of Advanced Ovarian Cancer'Jaipur, India, Jan 2009."
Papers:
6
Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: an analysis of 940 endometrioid endometrial cancer cases from the GOG0210 study
27
Serum mitochondrial DNA shows a greater effect size than CA-125 in predicting survival in epithelial ovarian cancer
45
Clinicopathologic features associated with defective DNA mismatch repair (MMR): a GOG0210 cohort study of 1041 endometrioid endometrial cancer cases
202
Limited training exposure in intraoperative radiation therapy (IORT) may result in omission of its use in treating locally advanced gynecologic malignancies
256
Oral contraceptive use and reproductive characteristics affect survival in patients with epithelial ovarian cancer
455
Lymphocyte nadir and reconstitution during chemotherapy predicts survival in ovarian cancer patients